VIX Archives - BioPharmaJournal

Pre-Market SPY moves up over 300

Kate Hudson - May 26, 2020 0

Markets pull back fearing the second COVID-19 wave

Gavins Felicity - May 21, 2020 0

COVID-19 vaccine trial drives market higher (SHOP,TDOC,NFLX,TWLO)

Gavins Felicity - May 18, 2020 0

S&P 500 heading for another major correction

Gavins Felicity - April 13, 2020 0

NASDAQ inches higher as VIX plummets

Gavins Felicity - March 31, 2020 0

VIX finally shows signs of stabilization

Gavins Felicity - March 20, 2020 0

S&P 500 (VIX) dips in pre market session for another blood...

Gavins Felicity - February 27, 2020 0

IPO’s to watch (ZCMD,NET)

Kate Hudson - February 19, 2020 0

Market ignores corona virus death toll numbers

Gavins Felicity - February 13, 2020 0

Dow Jones Industrial Average climbs up on corona virus updates

Kate Hudson - February 10, 2020 0

12 Page 1 of 2

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...

Kate Hudson - August 5, 2022 0

Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...

IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...

August 4, 2022

Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...

August 3, 2022

Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...

August 2, 2022

Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....

August 1, 2022

Tag: VIX

Recent Post